Esperion Therapeutics ESPR Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Esperion Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's operating margin?
- Esperion Therapeutics (ESPR) reported operating margin of 18.1% in Q1 2026.
- How has Esperion Therapeutics's operating margin changed year-over-year?
- Esperion Therapeutics's operating margin increased by 232.3% year-over-year, from -13.7% to 18.1%.
- What is the long-term trend for Esperion Therapeutics's operating margin?
- Over 5 years (2020 to 2025), Esperion Therapeutics's operating margin has grown at a -22.5% compound annual growth rate (CAGR), from -53.3% to 15%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.